Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, 560029, India.
Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India.
Tremor Other Hyperkinet Mov (N Y). 2024 Aug 21;14:41. doi: 10.5334/tohm.897. eCollection 2024.
Despite being the second most common type of neurodegeneration with brain iron accumulation, there is limited literature on -associated neurodegeneration (PLAN) within the Asian ethnicity, particularly in the Indian context.
We conducted a retrospective observational study on patients with pathogenic/likely pathogenic variants based on exome sequencing.
We identified 26 patients (22 families, 15 males) of genetically-confirmed PLAN with a median age of 22.5 years and age at onset of 13.0 years, encompassing various subtypes: infantile neuroaxonal dystrophy (5/26;19.2%), atypical neuroaxonal dystrophy (3/26;11.5%), dystonia-parkinsonism (5/26;19.2%), dystonia-parkinsonism-myoclonus (n = 4, 15.38%), early-onset Parkinson's disease (2/26;7.7%), complex dystonia (2/26;7.7%), and complicated hereditary spastic paraparesis (cHSP; 5/26;19.2%). The common initial symptoms included walking difficulty (7/26;26.9%), developmental regression (6/26;23.1%), and slowness (4/26;15.4%). Dystonia (14/26;53.8%), followed by parkinsonism (11/26; 42.3%), was the most common motor symptom. Non-motor symptoms included cognitive decline (12/26;46.2%) and behavioral changes (6/26;23.1%). Neuroimaging revealed cerebellar atrophy in 23/26 (88.5%) patients and claval hypertrophy in 80% (4/5) of INAD patients. Levodopa responsiveness was noted in 12 of 14 patients with parkinsonism/dystonia who received levodopa, and dyskinesia was noted in 10/11 patients. Genetic analysis revealed a total of 19 unique variants in gene, of which 11 were novel. Twelve patients harbored the c.2222G>A variant, which is predominantly seen in Asian subpopulations.
The study introduces 26 new patients of PLAN and 12 patients associated with the c.2222G>A variant, potentially forming the most extensive single center series to date. It also expands the phenotypic, neuroimaging, and genotypic spectrum of PLAN.
尽管铁沉积相关神经变性(PLAN)是仅次于额颞叶痴呆的第二大常见神经退行性疾病类型,但在亚洲人群中,尤其是在印度人群中,关于 PLAN 的相关文献非常有限。
我们对基于外显子组测序的致病性/可能致病性 变异患者进行了回顾性观察性研究。
我们共确定了 26 名(22 个家系,15 名男性)经基因检测确诊的 PLAN 患者,中位年龄为 22.5 岁,发病年龄为 13.0 岁,涵盖了多种亚型:婴儿型神经轴索营养不良(5/26;19.2%)、非典型神经轴索营养不良(3/26;11.5%)、肌张力障碍-帕金森病(5/26;19.2%)、肌张力障碍-帕金森病-肌阵挛(n=4,15.38%)、早发性帕金森病(2/26;7.7%)、复杂型肌张力障碍(2/26;7.7%)和复杂遗传性痉挛性截瘫(cHSP;5/26;19.2%)。常见的首发症状包括行走困难(7/26;26.9%)、发育倒退(6/26;23.1%)和动作缓慢(4/26;15.4%)。最常见的运动症状是肌张力障碍(14/26;53.8%),其次是帕金森病(11/26;42.3%)。非运动症状包括认知能力下降(12/26;46.2%)和行为改变(6/26;23.1%)。神经影像学显示 23/26(88.5%)患者存在小脑萎缩,80%(4/5)的 INAD 患者存在锁骨肥厚。14 名帕金森病/肌张力障碍患者中有 12 名接受左旋多巴治疗后出现反应性,11 名患者出现运动障碍。基因分析显示 基因共发现 19 种独特变异,其中 11 种为新变异。12 名患者携带 c.2222G>A 变异,该变异主要见于亚洲人群。
本研究介绍了 26 名新的 PLAN 患者和 12 名与 c.2222G>A 变异相关的患者,可能形成了迄今为止最广泛的单中心系列研究。它还扩展了 PLAN 的表型、神经影像学和基因型谱。